institution logo
If you're member of the institution,  you just have to login to download the file in restricted access. It is not necessary to request a print.

Request copy

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
Kim, Stefano; Ghiringhelli, Francois; de la Fouchardière, Christelle et al.
2024In The Lancet Oncology, 25 (4), p. 518 - 528

Document(s) requested
Kim Lancet Oncology 2024.pdf

The desired document is not currently available on open access. Nevertheless you can request an offprint through the form below. If your request is accepted you will receive by e-mail a link allowing you access to the document for 5 days, 5 download attempts maximum.


Request form

Fields marked with ✱ are compulsory.

Back to the reference
Contact ORBi